The effect of ascorbic acid ingestion on the biochemical and physicochemical risk factors associated with calcium oxalate kidney stone formation

Clinical Chemistry and Laboratory Medicine

Volumn 36, Issue 3, 1998, Pages 143-147

  Auer, Bronwyn Leigh ^a   Auer, Derek ^a   Rodgers, Allen Lawrence ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Ascorbic acid; Risk factors; Urinary oxalate; Urolithiasis; Vitamin C

Indexed keywords

2,6 DICHLOROPHENOLINDOPHENOL; ASCORBIC ACID; CALCIUM OXALATE;

ARTICLE; CALCIUM OXALATE STONE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR; URINALYSIS; UROLITHIASIS; VITAMIN INTAKE;

2,6-DICHLOROINDOPHENOL; ADULT; ASCORBIC ACID; CALCIUM OXALATE; HUMANS; KIDNEY CALCULI; MALE; RISK FACTORS; SOUTH AFRICA;

EID: 0031954563     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1998.027     Document Type: Article

References (21)

1. Tiselius HG, Almgard LE. The diurnal urinary excretion of oxalate and the effect of pyridoxine and ascorbate on oxalate excretion. Eur Urol 1977; 3:41-6.
2. Hatch M, Mulgrew S, Bourke E, Keogh B, Costello J. Effects of megadose ingestion of ascorbic acid on serum and urinary oxalate. Eur Urol 1980; 6:166-9.
3. Urivetzky M, Kessaris D, Smith AD. Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. J Urol 1992; 147:1215-8.
4. Lamden MP, Chrystowski GA. Urinary oxalate excretion by man following ascorbic acid ingestion. Proc Soc Exp Biol Med 1954; 85:190-2.
5. Chalmers AH, Cowley, DM, Brown JM. A possible etiological role for ascorbate in calculi formation. Clin Chem 1986; 32:333-6.
6. Trinchieri A, Mandressi A, Luongo P. The influence of diet on urinary risk factors for stones in healthy subjects and idiopathic renal calcium stone formers. Br J Urol 1991; 67:230-6.
7. Hughes C, Dutton S, Stewart-Truswell A. High intakes of ascorbic acid and urinary oxalate. J Hum Nutr 1981; 35:274-80.
8. Atkins GL, Dean BM, Griffin WG, Scowen EF, Watts RW. Quantitative aspects of ascorbic acid metabolism in patients with primary hyperoxaluria. Clin Sci 1965; 29:305-14.
9. Schmidt KH, Hagmaier V, Hornig DH, Vuilleumier JP, Rutishauser G. Urinary oxalate excretion after large intakes of ascorbic acid in man. Am J Clin Nutr 1981; 34:305-11.
10. Fituri N, Allawi N. Bentley M, Costello J. Urinary and plasma oxalate during ingestion of pure ascorbic acid: a re-evaluation. Eur Urol 1983; 9:312-5.
11. Tsao CS, Salimi SL. Effect of large intake of ascorbic acid on urinary and plasma oxalic acid levels. Int J Vit Nutr Res 1984; 54:245-9.
12. Chalmers AH, Cowley DM, McWhinney BC. Stability of ascorbate in urine: relevance to analysis for ascorbate and oxalate. Clin Chem 1985; 31:1703-5.
13. Davies MB, Austin J, Partridge DA. Vitamin C: its chemistry and biochemistry. London: Royal Society of Chemistry Paperbacks, 1991.
14. McMurray W, Gowenlock AH. Vitamins. In: Gowenlock AH, editor. Varleys practical clinical biochemistry, 6th ed. London: Heinemann Medical Books, 1988:894-930.
15. Werness PG, Brown CM, Smith LH, Finlayson B. EQUIL 2: a basic computer program for the calculation of urinary saturation. J Urol 1985; 134:1242-4.
16. Tiselius HG. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease. Clin Chim Acta 1982; 122:409-18.
17. SAS Institute, SAS User's Guide: Statistics, 1990, SAS Institute Inc., Cary, N. C.
18. Ralli EP, Friedman GJ, Rubin SH. The mechanism of excretion of vitamin C by the human kidney. J Clin Invest 1938; 17:756-70.
19. Atkins GL, Dean BM, Griffin WJ, Watts RW. Quanitative aspects of ascorbic acid metabolism in man. J Biol Chem 1964; 239:2975-80.
20. Conyers RA, Bais R, Rofe AM. Ascorbic acid intake, renal function and urinary oxalate excretion. Aust NZ J Med 1985; 15:353-5.
21. Lux B, May P. Long term observation of young cystinuric patients under ascorbic acid therapy. Urol Int 1983; 38:91-94.